19 related articles for article (PubMed ID: 8956380)
1. Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.
Newman-Tancredi A; Kleven MS
Psychopharmacology (Berl); 2011 Aug; 216(4):451-73. PubMed ID: 21394633
[TBL] [Abstract][Full Text] [Related]
2. Serotonin, inhibition, and negative mood.
Dayan P; Huys QJ
PLoS Comput Biol; 2008 Feb; 4(2):e4. PubMed ID: 18248087
[TBL] [Abstract][Full Text] [Related]
3. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
[TBL] [Abstract][Full Text] [Related]
4. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.
Wadenberg ML
J Neural Transm Gen Sect; 1992; 89(1-2):49-59. PubMed ID: 1418867
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
Wadenberg ML; Ahlenius S
J Neural Transm Gen Sect; 1991; 83(1-2):43-53. PubMed ID: 1673344
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
Wadenberg ML; Hertel P; Fernholm R; Hygge Blakeman K; Ahlenius S; Svensson TH
J Neural Transm (Vienna); 2000; 107(10):1229-38. PubMed ID: 11129112
[TBL] [Abstract][Full Text] [Related]
8. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.
Prinssen EP; Kleven MS; Koek W
Psychopharmacology (Berl); 1996 Nov; 128(2):191-7. PubMed ID: 8956380
[TBL] [Abstract][Full Text] [Related]
10. Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior.
Ahlenius S; Larsson K
Neurochem Res; 1997 Aug; 22(8):1065-70. PubMed ID: 9239763
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
